He X - Search Results

1

Treatment outcome of patients with stages I-II nasopharyngeal carcinoma after late course accelerated hyperfractionation radiotherapy alone.

He X, Ye M, Guo X, Pan Z, Zhang Z, He S, Liu T. He X, et al. Among authors: he s. Oral Oncol. 2012 Oct;48(10):1058-1063. doi: 10.1016/j.oraloncology.2012.05.008. Epub 2012 May 31. Oral Oncol. 2012. PMID: 22658301

2

Late course accelerated hyperfractionated radiotherapy of nasopharyngeal carcinoma (LCAF).

He XY, Liu TF, He SQ, Huan SL, Pan ZQ. He XY, et al. Radiother Oncol. 2007 Oct;85(1):29-35. doi: 10.1016/j.radonc.2007.08.005. Epub 2007 Sep 21. Radiother Oncol. 2007. PMID: 17889386 Clinical Trial.

3

Paclitaxel with cisplatin in concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma.

He XY, Hu CS, Ying HM, Wu YR, Zhu GP, Liu TF. He XY, et al. Eur Arch Otorhinolaryngol. 2010 May;267(5):773-8. doi: 10.1007/s00405-009-1112-7. Epub 2009 Oct 10. Eur Arch Otorhinolaryngol. 2010. PMID: 19820959

4

Preliminary results of a phase III randomized study comparing chemotherapy neoadjuvantly or concurrently with radiotherapy for locoregionally advanced nasopharyngeal carcinoma.

Xu T, Hu C, Zhu G, He X, Wu Y, Ying H. Xu T, et al. Among authors: he x. Med Oncol. 2012 Mar;29(1):272-8. doi: 10.1007/s12032-010-9803-x. Epub 2011 Jan 30. Med Oncol. 2012. PMID: 21279704 Clinical Trial.

5

Experience with combination of cisplatin plus gemcitabine chemotherapy and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma.

He X, Ou D, Ying H, Zhu G, Hu C, Liu T. He X, et al. Eur Arch Otorhinolaryngol. 2012 Mar;269(3):1027-33. doi: 10.1007/s00405-011-1669-9. Epub 2011 Jun 26. Eur Arch Otorhinolaryngol. 2012. PMID: 21706324 Clinical Trial.

6

A phase III study of late course accelerated hyperfractionated radiotherapy versus conventionally fractionated radiotherapy in patients with nasopharyngeal carcinoma.

Pan ZQ, He XY, Guo XM, Ye M, Zhang Z, He SQ, Liu TF. Pan ZQ, et al. Am J Clin Oncol. 2012 Dec;35(6):600-5. doi: 10.1097/COC.0b013e31822dfd55. Am J Clin Oncol. 2012. PMID: 22134512 Clinical Trial.

7

The pattern of relapse and survival of elective irradiation of the upper neck for stage N0 nasopharyngeal carcinoma.

He X, Pan Z, Guo X, Ye M, Zhang Z, He S, Liu T. He X, et al. Among authors: he s. Radiat Oncol. 2012 Mar 19;7:35. doi: 10.1186/1748-717X-7-35. Radiat Oncol. 2012. PMID: 22429900 Free PMC article. Clinical Trial.

8

Magnetic resonance sialography for investigating major salivary gland duct system after intensity-modulated radiotherapy of nasopharyngeal carcinoma.

Ou D, Zhang Y, He X, Gu Y, Hu C, Ying H, Zhu G, Wu Y, Mao J, Yue L, Shen X. Ou D, et al. Among authors: he x. Int J Clin Oncol. 2013 Oct;18(5):801-7. doi: 10.1007/s10147-012-0464-y. Epub 2012 Aug 15. Int J Clin Oncol. 2013. PMID: 22892798

9

A phase III randomized study comparing neoadjuvant chemotherapy with concurrent chemotherapy combined with radiotherapy for locoregionally advanced nasopharyngeal carcinoma: updated long-term survival outcomes.

Xu T, Zhu G, He X, Ying H, Hu C. Xu T, et al. Among authors: he x. Oral Oncol. 2014 Feb;50(2):71-6. doi: 10.1016/j.oraloncology.2013.11.002. Epub 2013 Dec 5. Oral Oncol. 2014. PMID: 24315404 Clinical Trial.

10

Sparing level Ib lymph nodes by intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma.

Chen J, Ou D, He X, Hu C. Chen J, et al. Among authors: he x. Int J Clin Oncol. 2014 Dec;19(6):998-1004. doi: 10.1007/s10147-013-0650-6. Epub 2013 Dec 12. Int J Clin Oncol. 2014. PMID: 24337503

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29,356 results

Search Page

Filters